CR vs CXT: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CXT is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CR and CXT share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CR and CXT exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Crane Company became a standalone public company in April 2023 when Crane Holdings separated into two businesses, with the industrial operations listing as CR (the payments-and-authentication side became Crane NXT). The company runs two segments: Aerospace & Advanced Technologies, which supplies power conversion, actuation, sensing and thermal-management systems for commercial aircraft, military platforms and space, and Process Flow Technologies, which makes valves, pumps, instrumentation and cryogenic systems for chemical, pharmaceutical, water and energy customers.

Full CR guide

Crane NXT, Co. makes the physical things that prove something is real and that money is money. Its Security and Authentication Technologies segment contains Crane Currency, a roughly 225-year-old business that supplies banknote paper and micro-optic security features to the US Bureau of Engraving and Printing and to central banks abroad, plus Crane Authentication, the brand-protection and government-credential unit assembled from OpSec Security and the De La Rue Authentication business bought in May 2025 for ~300 million pounds. The Detection and Traceability Technologies segment holds Crane Payment Innovations, whose bill validators, coin mechanisms and cash-recycling hardware sit inside vending machines, slot machines, self-checkout lanes and bank branches, and now Antares Vision, the Italian inspection and track-and-trace supplier acquired on April 1, 2026 and delisted from Euronext Milan. The company became a standalone issuer on April 3, 2023, when Crane Holdings separated its aerospace, industrial and process-flow operations into Crane Company (NYSE: CR) and kept the payment and security businesses under the Crane NXT name.

Full CXT guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CR drivers: Aerospace and defense demand; Process Flow Technologies and cryogenics.
• CXT drivers: Currency and authentication backlog at a record; The bought pivot into authentication and traceability.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Crane trades at a premium valuation (around 30 times earnings), so any slowdown in growth or margin misstep could pressure the stock. For CXT, the clearest risk is that headline growth is purchased and organic growth is barely positive, so a slower integration or a missed synergy target shows up immediately in the numbers with no underlying momentum to cushion it.

Pick CR if you believe its drivers more; CXT if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CR and CXT guides.

CR. Crane reported roughly 25% net-sales growth in Q1 2026 (about 4% organic plus acquisitions) and raised full-year adjusted EPS guidance. Adjusted operating margin was near 19.8% while GAAP EPS declined on acquisition-related items. The shares carry a premium multiple around 30 times earnings, reflecting expectations for continued growth.

CXT. Q2 2026 adjusted EPS of ~$1.10 beat consensus near ~$1.04 and management lifted the full-year adjusted EPS range while leaving sales growth at ~15% to ~17% and adjusted EBITDA margin near ~24%. Total backlog reached ~$755 million, split ~$498 million in Security and Authentication and ~$257 million in Detection and Traceability. The stock trades roughly a quarter below its ~$69 52-week high, and the low forward multiple mainly reflects the market pricing acquisition-driven earnings and ~2.7x leverage more conservatively than organic earnings.

Headline figures (approximate, July 2026): CR shows revenue (ttm) ~$2.5B, q1 2026 revenue ~$696M (+25% YoY), adjusted eps (q1 2026) ~$1.65 (+15% YoY), fy2026 adjusted eps guidance ~$6.65 to $6.85; CXT shows revenue (ttm) ~$1.80B, q2 2026 sales ~$493M (+22% YoY, ~+2.8% organic), fy2026 adjusted eps guidance ~$4.22 to ~$4.42, market cap ~$3.0B at ~$52 per share.

CR and CXT are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CR and CXT exposure against your real portfolio. It is not an investment adviser.